All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Stage II Prostate Cancer AJCC v7 | NCIT_C89233 | [Stage II includes: IIA (T1a-c, N0, M0, PSA less than 20, Gleason 7); (T1a-c, N0, M0, PSA equal or more than 10 and less than 20, Gleason equal or less than 6); (T2a, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA X, Gleason X); IIB (T2c, N0, M0, Any PSA, Any Gleason); (T1-2, N0, M0, PSA equal or more than 20, Any Gleason); (T1-2, N0, M0, Any PSA, Gleason equal or more than 8). T1a: Tumor incidental histologic finding in 5% or less of tissue resected. T1b: Tumor incidental histologic finding in more than 5% of tissue resected. T1c: Tumor identified by needle biopsy (e.g., because of elevated PSA). T2a: Tumor involves one-half of one lobe or less. T2b: Tumor involves more than one-half of one lobe, but not both lobes. T2c: Tumor involves both lobes. cN0: No regional lymph node metastasis. pN0: No positive regional nodes. M0: No distant metastasis. Gleason 7: Moderately differentiated (moderate anaplasia). Gleason Equal or Less than 6: Well differentiated (slight anaplasia). Gleason equal or more than 8: Poorly differentiated/undifferentiated (marked anaplasia). (AJCC 7th ed.)] |
| Quintamillesimal Series of Attenuation | NCIT_C88108 | [Preparation of a homeopathic substance with a ratio of one part original material to 50,000 parts of carrier or solvent, traditionally this is lactose, water or ethanol.] |
| Homeopathic Dilution Unit | NCIT_C48498 | [A dosing unit that is based on homeopathic dilution.] |
| Centesimal Series of Attenuation | NCIT_C88109 | [Preparation of a homeopathic substance with a ratio of one part original material to 100 parts of carrier or solvent, traditionally lactose, water or ethanol.] |
| Stage IIB Pancreatic Cancer AJCC v6 and v7 | NCIT_C88103 | [Stage IIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T1: Tumor limited to the pancreas, 2 cm or less in greatest dimension. T2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. T3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery. N1: Regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)] |
| Stage IIIa Penile Cancer AJCC v7 | NCIT_C88104 | [Stage IIIa includes: T1-3, N1, M0. T1: Tumor invades subepithelial connective tissue without lymph vascular invasion and is not poorly differentiated (i.e., grade 3-4) or tumor invades subepithelial connective tissue with lymph vascular invasion or is poorly differentiated. T2: Tumor invades corpus spongiosum or cavernosum. T3: Tumor invades urethra. cN1: Palpable mobile unilateral inguinal lymph node. pN1: Metastasis in a single inguinal lymph node. M0: No distant metastasis. (AJCC 7th ed.)] |
| Stage III Penile Cancer AJCC v7 | NCIT_C89197 | [Stage III includes: IIIa (T1-3, N1, M0); IIIb (T1-3, N2, M0). T1: Tumor invades subepithelial connective tissue without lymph vascular invasion and is not poorly differentiated (i.e., grade 3-4) or tumor invades subepithelial connective tissue with lymph vascular invasion or is poorly differentiated. T2: Tumor invades corpus spongiosum or cavernosum. T3: Tumor invades urethra. cN1: Palpable mobile unilateral inguinal lymph node. pN1: Metastasis in a single inguinal lymph node. cN2: Palpable mobile multiple or bilateral inguinal lymph nodes. pN2: Metastasis in multiple or bilateral superficial inguinal lymph nodes. M0: No distant metastasis. (AJCC 7th ed.)] |
| Stage IIIb Penile Cancer AJCC v7 | NCIT_C88105 | [Stage IIIb includes: T1-3, N2, M0. T1: Tumor invades subepithelial connective tissue without lymph vascular invasion and is not poorly differentiated (i.e., grade 3-4) or tumor invades subepithelial connective tissue with lymph vascular invasion or is poorly differentiated. T2: Tumor invades corpus spongiosum or cavernosum. T3: Tumor invades urethra. cN2: Palpable mobile multiple or bilateral inguinal lymph nodes. pN2: Metastasis in multiple or bilateral superficial inguinal lymph nodes. M0: No distant metastasis. (AJCC 7th ed.)] |
| Stage IIA Prostate Cancer AJCC v7 | NCIT_C88106 | [Stage IIA includes: (T1a-c, N0, M0, PSA less than 20, Gleason 7); (T1a-c, N0, M0, PSA equal or more than 10 and less than 20, Gleason equal or less than 6); (T2a, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA X, Gleason X). T1a: Tumor incidental histologic finding in 5% or less of tissue resected. T1b: Tumor incidental histologic finding in more than 5% of tissue resected. T1c: Tumor identified by needle biopsy (e.g., because of elevated PSA). T2a: Tumor involves one-half of one lobe or less. T2b: Tumor involves more than one-half of one lobe, but not both lobes. cN0: No regional lymph node metastasis. pN0: No positive regional nodes. M0: No distant metastasis. Gleason 7: Moderately differentiated (moderate anaplasia). Gleason Equal or Less than 6: Well differentiated (slight anaplasia). (AJCC 7th ed.)] |
| Millesimal Series of Attenuation | NCIT_C88110 | [Preparation of a homeopathic substance with a ratio of one part original material to 1000 parts of carrier or solvent, traditionally lactose, water or ethanol.] |
| Decimal Series of Attenuation | NCIT_C88111 | [Preparation of a homeopathic substance with a ratio of one part original material to 10 parts of carrier or solvent, traditionally lactose, water or ethanol.] |
| Photon | NCIT_C88112 | [A single unit of electromagnetic radiation, generally considered to be a discrete particle having no mass or charge.] |
| Electromagnetic Radiation | NCIT_C17050 | [The radiation of energy as transverse waves produced by moving charges.] |
| Free Cortisol Measurement | NCIT_C88113 | [The determination of the amount of free, unbound cortisol present in a sample.] |
| Patient Care | NCIT_C15239 | [Any of the services rendered for the benefit of a patient.] |
| Tyrosine-Protein Kinase Transmembrane Receptor ROR2 | NCIT_C29880 | [Tyrosine-protein kinase transmembrane receptor ROR2 (937 aa, ~105 kDa) is encoded by the human ROR2 gene. This protein is involved in both cartilage formation and receptor signaling.] |
| Nuclear Receptor ROR-Alpha | NCIT_C29881 | [Nuclear receptor ROR-alpha (556 aa, ~63 kDa) is encoded by the human RORA gene. This protein is involved in the positive regulation of transcription.] |
| Nuclear Orphan Receptor | NCIT_C20036 | [Transcription factors in the nuclear receptor superfamily for which a natural ligand has not been identified.] |
| 60S Ribosomal Protein L10 | NCIT_C29882 | [60S ribosomal protein L10 (214 aa, ~25 kDa) is encoded by the human RPL10 gene. This protein plays a role in the function and structure of the large ribosomal subunit.] |
| Arsanilic Acid | NCIT_C29883 | [An organoarsenic compound with activity as an anti-infective agent. As a feed additive, arsanilic acid improves weight gain in farm-raised animals, but its use as a growth promoter is banned in many countries.] |